Tyrosine Kinase
Tyrosine Kinase(酪氨酸激酶)
- Bcr-Abl(73)
- Ack1(3)
- Axl(6)
- ALK(64)
- BMX Kinase(3)
- Broad Spectrum Protein Kinase Inhibitor(10)
- c-FMS(42)
- c-Kit(58)
- c-MET(99)
- c-RET(7)
- CSF-1R(3)
- DDR1/DDR2 Receptor(1)
- EGFR(278)
- EphB4(1)
- FAK(39)
- FGFR(104)
- FLT3(97)
- HER2(15)
- IGF1R(34)
- Insulin Receptor(46)
- IRAK(32)
- ITK(10)
- Lck(1)
- LRRK2(25)
- PDGFR(113)
- PTKs/RTKs(10)
- Pyk2(8)
- ROR(41)
- Spleen Tyrosine Kinase (Syk)(33)
- Src(108)
- Tie-2 (4)
- Trk(43)
- VEGFR(200)
- Kinase
- Discoidin Domain Receptor(16)
- DYRK(35)
- Ephrin Receptor(13)
- RET(30)
- ROS(14)
- TAM Receptor(33)
- IGFBR(1)
- Others(55)
Tyrosine Kinase 相关产品(1402)
- GC45754Lenvatinib-d4CAS: 2264050-65-7纯度: >99.00%
Lenvatinib-d4 (E7080-d4) 是氘标记的 Lenvatinib。 Lenvatinib (E7080) 是一种口服的多靶点酪氨酸激酶抑制剂，可抑制 VEGFR1-3、FGFR1-4、PDGFR、KIT 和 RET，显示出有效的抗肿瘤活性。
- GC45767Dovitinib-d8CAS: 1246819-84-0纯度: >99.00%
An internal standard for the quantification of dovitinib
- GC45769Vandetanib-d6CAS: 1174683-49-8纯度: >99.00%
An internal standard for the quantification of vandetanib
- GC45789Ceritinib-d7CAS: 1632484-77-5纯度: >99.00%
An internal standard for the quantification of ceritinib
- GC45828Ponatinib-d8CAS: 1562993-37-6纯度: >99.00%
An internal standard for the quantification of ponatinib
- GC46123Comprehensive Kinase Screening Library纯度: >98.00%
For screening of a variety of kinase inhibitors
- GC46304(±)-Nebivolol-d4 (hydrochloride)CAS: 2701283-32-9纯度: >99.00%
A neuropeptide with diverse biological activities
- GC4647418-DeoxyherboxidieneCAS: 1200128-66-0纯度: >70.00%
A bacterial metabolite with antiangiogenic activity
- GC464901-Palmitoyl-d3-2-hydroxy-sn-glycero-3-PCCAS: 2692624-19-2纯度: >99.00%
A neuropeptide with diverse biological activities
- GC466284-Chloro-6,7-bis(2-methoxyethoxy)quinazolineCAS: 183322-18-1纯度: >95.00%
A building block and synthetic intermediate
- GC46809Afatinib-d6CAS: 1313874-96-2纯度: >99.00%
An internal standard for the quantification of afatinib
- GC46899Axitinib-13C-d3CAS: 1261432-00-1纯度: >99.00%
An internal standard for the quantification of axitinib
- GC47182Dehydrolithocholic AcidCAS: 1553-56-6纯度: >95.00% / >98.00%
Dehydrolithocholic Acid（脱氢石胆酸；3-Oxo-5β-cholanoic acid；3-oxoLCA；DLA）是一种胆汁酸代谢产物，通过与维甲酸受体相关孤儿受体（RORγt）相互作用可抑制T辅助细胞17（Th17）分化。
- GC47303Erlotinib-d6 (hydrochloride)CAS: 1189953-78-3纯度: >99.00%
An internal standard for the quantification of erlotinib
- GC47321Etifoxine-13C-d3CAS: 2738376-67-3纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47350Finasteride-d9CAS: 1131342-85-2纯度: >99.00%
An internal standard for the quantification of finasteride
- GC47393Ganglioside GM1 Mixture (porcine brain) (ammonium salt)CAS: 1007119-81-4纯度: >98.00%
A sphingolipid
- GC47395Gefitinib-d6CAS: 1228664-49-0纯度: >99.00%
An internal standard for the quantification of gefitinib
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC45754 | Lenvatinib-d4 | 2264050-65-7 | >99.00% | |
Lenvatinib-d4 (E7080-d4) 是氘标记的 Lenvatinib。 Lenvatinib (E7080) 是一种口服的多靶点酪氨酸激酶抑制剂，可抑制 VEGFR1-3、FGFR1-4、PDGFR、KIT 和 RET，显示出有效的抗肿瘤活性。 | ||||
| GC45767 | Dovitinib-d8 | 1246819-84-0 | >99.00% | |
An internal standard for the quantification of dovitinib | ||||
| GC45769 | Vandetanib-d6 | 1174683-49-8 | >99.00% | |
An internal standard for the quantification of vandetanib | ||||
| GC45789 | Ceritinib-d7 | 1632484-77-5 | >99.00% | |
An internal standard for the quantification of ceritinib | ||||
| GC45828 | Ponatinib-d8 | 1562993-37-6 | >99.00% | |
An internal standard for the quantification of ponatinib | ||||
| GC45831 | SRI-011381 | 1629138-41-5 | >99.50% | |
SRI-011381是一种具口服活性的转化生长因子β（TGF-β）信号通路的激活剂，具有神经保护作用。 | ||||
| GC46013 | AS-2444697 (hydrochloride) | 1287665-60-4 | >95.00% | |
An IRAK4 inhibitor | ||||
| GC46123 | Comprehensive Kinase Screening Library | - | >98.00% | |
For screening of a variety of kinase inhibitors | ||||
| GC46197 | PD 90780 (hydrate) | - | >98.00% | |
An inhibitor of NGF-p75 NGFR interactions | ||||
| GC46208 | Propentofylline | 55242-55-2 | >98.00% | |
A xanthine derivative and neuroprotective agent | ||||
| GC46304 | (±)-Nebivolol-d4 (hydrochloride) | 2701283-32-9 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46474 | 18-Deoxyherboxidiene | 1200128-66-0 | >70.00% | |
A bacterial metabolite with antiangiogenic activity | ||||
| GC46490 | 1-Palmitoyl-d3-2-hydroxy-sn-glycero-3-PC | 2692624-19-2 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46628 | 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline | 183322-18-1 | >95.00% | |
A building block and synthetic intermediate | ||||
| GC46809 | Afatinib-d6 | 1313874-96-2 | >99.00% | |
An internal standard for the quantification of afatinib | ||||
| GC46899 | Axitinib-13C-d3 | 1261432-00-1 | >99.00% | |
An internal standard for the quantification of axitinib | ||||
| GC46924 | BIBF 1120-13C-d3 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47182 | Dehydrolithocholic Acid | 1553-56-6 | >95.00% / >98.00% | |
Dehydrolithocholic Acid（脱氢石胆酸；3-Oxo-5β-cholanoic acid；3-oxoLCA；DLA）是一种胆汁酸代谢产物，通过与维甲酸受体相关孤儿受体（RORγt）相互作用可抑制T辅助细胞17（Th17）分化。 | ||||
| GC47303 | Erlotinib-d6 (hydrochloride) | 1189953-78-3 | >99.00% | |
An internal standard for the quantification of erlotinib | ||||
| GC47321 | Etifoxine-13C-d3 | 2738376-67-3 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47350 | Finasteride-d9 | 1131342-85-2 | >99.00% | |
An internal standard for the quantification of finasteride | ||||
| GC47392 | Ganglioside GM1 Mixture (ovine) (ammonium salt) | 1007119-81-4 | >98.00% | |
A sphingolipid | ||||
| GC47393 | Ganglioside GM1 Mixture (porcine brain) (ammonium salt) | 1007119-81-4 | >98.00% | |
A sphingolipid | ||||
| GC47395 | Gefitinib-d6 | 1228664-49-0 | >99.00% | |
An internal standard for the quantification of gefitinib | ||||